Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-04-30

Evaluation of the Biosafety of lead substitutes Used in the Manufacture of Unleaded Crystal Glass

Objective



Currently crystal glass contains either 24% or 32% lead. In use, lead may leach from crystal into liquids which may be subsequently drunk, resulting in lead intake by the general public. This intake is regarded as unacceptable by groups in some countries (e.g. USA) and therefore there is pressure to remove lead from crystal and replace it with G safer substitute. Whilst a lot is known about lead toxicity, relatively little is known the bioavailability, toxicity and behaviour of substitutes in the body The aim of the project is to provide the European Crystal Industry with the biological information for the production of a safety case for genetic unleaded crystal compositions.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

EAW - Exploratory awards

Coordinator

Royal Brierley Crystal
EU contribution
No data
Address
North Street
DY5 3SJ Brierley Hill
United Kingdom
Total cost
No data